NorthWest Biotherapeutics Inc (NWBO)

[SkyLimit2022]

Inquirig,

Thanks for asking. Most of your lies are presented in the form of baseless innuendo and conjecture or vague defamatory comments. Plausible deniability does not mean that your posts are forthright good-faith opinions—misleading statements are dishonest…

It seems like you post a lot of nonsense to spread rumors. If you wish to share a viewpoint based on full-context sources, or if you wish to share a credible full-context source link, then readers might consider reviewing those texts to evaluate their relevance for themselves. Your random fud commentary is not effective.

The sources below are examples of sources that anyone can evaluate and research further for themselves. Certified and practicing financial professionals, actual patients, and licensed oncologists are reasonable sources of information—Each person named below can be assessed for credibility and level of expertise—we can decide how reliable their statements are by exploring their background experience or credentials. In contrast to the sources below, your anonymous analyses and reckless predictions cannot be evaluated and are not real sources of anything worth reading or discussing.

https://t.co/BfFA5i4OoT $nwbo @alphavestcap @ItsMikePoarch https://t.co/h8nQ3MiOPV pic.twitter.com/Ly4v6PPmzT

— alphavestcapital.com (@alphavestcap) February 3, 2024

$nwbo https://t.co/tRKkESt5Sf

— Kelly (@Kelly712717541) February 3, 2024

The $NWBO Discussion of the Century is HERE: Join @LisainNJUSA @ThomasOwenMcCa1 and I discussing DCVax-L, #nwbo and How Thomas is ALIVE Today because of this extraordinary NEW Cancer Treatment That's Potentially Applicable to Over 90% of All Cancers: https://t.co/smtuAU5fDf

— Michael Poarch (@ItsMikePoarch) February 1, 2024

This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated with improved survival in both newly diagnosed & recurrent glioblastoma compared with matched controls who received SOC treatment. https://t.co/Uso7Pkh1Kt

— JAMA Oncology (@JAMAOnc) February 15, 2023

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173720548